Hoffmann38 proposed a diagnostic method to detect ErbB2 amplification in single disseminated cancer cells, demonstrating that ErbB2 amplification in esophageal cancer patients is significantly correlated with short-term survival. This evidence concerns the gene ERBB2 and cancer.